![]() |
市場調査レポート
商品コード
1619216
血液検査の市場規模、シェア、成長分析、タイプ別、方法別、エンドユーザー別、地域別- 産業予測、2024~2031年Blood Testing Market Size, Share, Growth Analysis, By Type (Glucose Testing, Lipid Panel Testing), By Methods (Manual Blood Testing, Automated Blood Testing), By End User, By Region - Industry Forecast 2024-2031 |
||||||
|
血液検査の市場規模、シェア、成長分析、タイプ別、方法別、エンドユーザー別、地域別- 産業予測、2024~2031年 |
出版日: 2024年12月20日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
血液検査の世界市場規模は、2022年に956億5,000万米ドルと評価され、2023年の1,034億9,000万米ドルから2031年には1,944億2,000万米ドルに成長し、予測期間中(2024年~2031年)のCAGRは8.2%で成長する見通しです。
世界の血液検査市場は、政府部門と民間部門の両方による医療支出の増加により、大きな成長を遂げると予測されています。多国籍医療機関は、革新的な技術を積極的に開発し、慢性疾患に対する意識を高めており、血液検査の需要をさらに促進しています。2031年までに7億8,300万人の成人が罹患すると予想される糖尿病を中心とする慢性疾患の増加は、健康評価製品に対する大きな需要を生み出します。CMSやFDAのような規制機関は、疾病の早期発見を強化するCLIA準拠の診断検査を推進する上で極めて重要です。このような規制当局の支援の急増と健康への関心の高まりは、血液検査分野の事業全体に有利な機会を提供し、今後数年間の市場の堅調な拡大を位置付けています。
Global Blood Testing Market size was valued at USD 95.65 billion in 2022 and is poised to grow from USD 103.49 billion in 2023 to USD 194.42 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).
The global blood testing market is projected to experience significant growth, fueled by increasing medical expenditures from both government and private sectors. Multinational healthcare organizations are actively developing innovative techniques and raising awareness about chronic diseases, further driving demand for blood testing. The rise in chronic disease prevalence, especially diabetes-expected to affect 783 million adults by 2031-will create substantial demand for health assessment products. Regulatory bodies like CMS and FDA are pivotal in promoting CLIA-compliant diagnostic tests that enhance early disease detection. This surge in regulatory support and rising health concerns offers lucrative opportunities for operational entities within the blood testing sector, positioning it for robust market expansion in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Blood Testing Market Segmental Analysis
Global Blood Testing Market is segmented by type, methods, end user and region. Based on type, the market is segmented into glucose testing, lipid panel testing, prostate specific antigen (PSA) testing, blood urea nitrogen (BUN) testing, thyroid stimulating hormone testing and other types (Direct LDL Testing, Testosterone Testing). Based on methods, the market is segmented into manual blood testing and automated blood testing. Based on end user, the market is segmented into diagnostic laboratories, hospitals and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Blood Testing Market
The Global Blood Testing market is significantly influenced by several key drivers that contribute to its growth. One of the most crucial factors is the influx of external funding directed towards clinical studies focused on innovating advanced diagnostic technologies. Additionally, as patient awareness regarding various self-testing and home diagnostic options rises, this trend is expected to further boost the market. Moreover, the increasing prevalence of chronic diseases, coupled with a heightened demand for rapid health assessment products, suggests a strong upward trajectory for the global blood testing market in the upcoming years. These elements collectively create a favorable environment for market expansion.
Restraints in the Global Blood Testing Market
The Global Blood Testing market faces significant challenges that may impede its growth, particularly in developing nations like India, Indonesia, and Malaysia. A key restraint is the limited awareness among patients regarding advanced technological devices, which can inhibit adoption rates. Additionally, the high costs associated with these devices and self-testing kits are anticipated to further suppress market demand in the foreseeable future. These factors collectively contribute to a slower market advancement, highlighting the need for increased education and more affordable options to enhance accessibility and utilization of blood testing technologies in these regions.
Market Trends of the Global Blood Testing Market
The global blood testing market is witnessing significant growth driven by advancements in technology and a surge in demand for accurate diagnostic solutions. Key players are increasingly leveraging innovations, particularly Artificial Intelligence, to enhance the precision and speed of disease detection, enabling early intervention and improved patient outcomes. This focus on integrating cutting-edge technologies not only streamlines testing processes but also caters to the evolving needs of healthcare providers and patients alike. As a result, the market is poised for expansion, with a notable emphasis on developing user-friendly products that enhance accessibility and efficiency, thereby reshaping the landscape of blood diagnostics worldwide.